Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Market Cap	12.41B
Revenue (ttm)	2.02B
Net Income (ttm)	-230.57M
Shares Out	9.13B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (1.58%)
Ex-Dividend Date	Sep 27, 2024

Volume	64,985,770
Average Volume	106,851,399
Open	1.330
Previous Close	1.330
Day's Range	1.310 - 1.360
52-Week Range	0.495 - 1.440
Beta	0.70
RSI	66.40
Earnings Date	Aug 29, 2025

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,667
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0460

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY